Gastroparesis is a chronic condition characterized by delayed gastric emptying without a physical blockage. This means food stays in your stomach longer than usual, which can cause symptoms ranging from bloating to malnutrition.
But is there a link between gastroparesis and popular weight loss drugs like semaglutide?
Board-certified gastroenterologist Dr. Prem Chattoo and his team at Hudson River Gastroenterology are happy to address the most common questions they encounter regarding semaglutide and its effects on your digestive health.
Gastroparesis is a disorder affecting nerves and muscles that normally move stomach contents into the small intestine, causing delayed emptying. This delay can lead to symptoms such as:
Depending on the severity, gastroparesis can eventually cause malnutrition and other serious health concerns. Sometimes the contents form a hardened mass called a bezoar that may require surgery.
Common causes of gastroparesis include diabetes, certain medications, and nerve damage affecting stomach motility. In some cases, the cause remains unknown (idiopathic gastroparesis).
Semaglutide belongs to a class of medications known as GLP-1 receptor agonists. Initially developed to treat type 2 diabetes, it works by enhancing insulin secretion, suppressing glucagon, and slowing gastric emptying.
This intentional delay in stomach emptying helps regulate blood sugar levels and contributes to weight loss by increasing feelings of fullness.
Semaglutide doesn’t directly cause gastroparesis, but it can mimic or exacerbate its symptoms.
Because the medication intentionally slows gastric emptying, some patients may experience nausea, fullness, or bloating, symptoms similar to gastroparesis. In most cases, these effects are dose-dependent and improve over time as the body adjusts.
However, in individuals with pre-existing gastroparesis or underlying motility disorders, semaglutide may worsen symptoms significantly.
Certain individuals may be more susceptible to gastrointestinal side effects from semaglutide, including:
Careful screening and gradual dose adjustments are important to minimize risk.
While mild gastrointestinal symptoms are common when starting semaglutide, more concerning signs may indicate a problem:
If these symptoms persist or worsen, it’s important to schedule a consultation with Dr. Chattoo promptly.
In general, semaglutide isn’t recommended for patients with moderate-to-severe gastroparesis. For mild cases, a physician may consider its use with caution while closely monitoring symptoms.
Alternative therapies may be more appropriate depending on individual risk factors and treatment goals.
Dr. Chattoo specializes in treating semaglutide side effects and encourages individuals to seek medical support early.
If gastrointestinal symptoms occur, several strategies may help, such as:
In some cases, discontinuation may be necessary if symptoms are severe.
We encourage individuals to schedule an appointment whenever they’re concerned about their digestive health.
However, you should definitely seek medical attention if you experience severe or persistent symptoms, especially vomiting, dehydration, or inability to eat. Dr. Chattoo may recommend diagnostic testing, such as a gastric emptying study, to evaluate for gastroparesis.
Semaglutide is an effective and widely used medication, but its impact on gastric motility requires careful consideration. While it doesn’t directly cause gastroparesis, it can worsen or mimic its symptoms, particularly in at-risk individuals.
Open communication with your healthcare provider is essential to ensure safe and effective treatment tailored to your needs.
Schedule a visit with Dr. Chattoo at Hudson River Gastroenterology today. Give our office a call or request an appointment online.
